Green Cross Medical Science Corporation (KOSDAQ: 142280)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,860.00
-40.00 (-1.03%)
Jan 22, 2025, 3:00 PM KST

Green Cross Medical Science Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Operating Revenue
99,71694,011113,109101,675113,37781,493
Upgrade
Other Revenue
0--0-0-
Upgrade
Revenue
99,71694,011113,109101,675113,37781,493
Upgrade
Revenue Growth (YoY)
1.78%-16.88%11.25%-10.32%39.13%-5.59%
Upgrade
Cost of Revenue
86,03880,056100,363100,04393,60172,208
Upgrade
Gross Profit
13,67913,95512,7461,63119,7779,285
Upgrade
Selling, General & Admin
7,7207,70810,05111,39911,9469,318
Upgrade
Research & Development
3,3052,8802,1672,1342,6542,188
Upgrade
Other Operating Expenses
74.8877.0295.8492.4370.0763.87
Upgrade
Operating Expenses
12,89212,68314,55421,79515,57812,301
Upgrade
Operating Income
787.041,272-1,808-20,1644,199-3,016
Upgrade
Interest Expense
-3,009-3,309-2,875-1,172-466.8-870.78
Upgrade
Interest & Investment Income
196.18273.96394.8526.274632.6
Upgrade
Currency Exchange Gain (Loss)
18.69-14.8741.8953.98-140.668.17
Upgrade
Other Non Operating Income (Expenses)
3,2924,050641.8189.113,439-5,684
Upgrade
EBT Excluding Unusual Items
1,2852,272-3,605-21,1677,076-9,530
Upgrade
Gain (Loss) on Sale of Investments
-396.55-396.55650.6949.9834.5623.52
Upgrade
Gain (Loss) on Sale of Assets
-212.38-9.993.558.38127.232.48
Upgrade
Asset Writedown
------1,988
Upgrade
Other Unusual Items
-565.09----120.81
Upgrade
Pretax Income
111.21,865-2,951-21,1087,238-11,372
Upgrade
Income Tax Expense
-16.43-11.34108.0729.84210.74-
Upgrade
Earnings From Continuing Operations
127.631,877-3,059-21,1387,027-11,372
Upgrade
Earnings From Discontinued Operations
----162.96-4,979
Upgrade
Net Income to Company
127.631,877-3,059-21,1387,190-16,350
Upgrade
Minority Interest in Earnings
22.51-79.45-521.86-64.04-473.11145.39
Upgrade
Net Income
150.141,797-3,581-21,2026,717-16,205
Upgrade
Net Income to Common
150.141,797-3,581-21,2026,717-16,205
Upgrade
Shares Outstanding (Basic)
222121212111
Upgrade
Shares Outstanding (Diluted)
242721212111
Upgrade
Shares Change (YoY)
13.23%26.96%0.05%-90.86%16.07%
Upgrade
EPS (Basic)
6.9785.25-169.87-1006.40318.83-1468.10
Upgrade
EPS (Diluted)
6.9775.80-170.00-1006.40318.83-1468.10
Upgrade
Free Cash Flow
283.28-1,3917,454-21,793-11,314-26,568
Upgrade
Free Cash Flow Per Share
11.87-51.96353.61-1034.47-537.04-2406.91
Upgrade
Gross Margin
13.72%14.84%11.27%1.60%17.44%11.39%
Upgrade
Operating Margin
0.79%1.35%-1.60%-19.83%3.70%-3.70%
Upgrade
Profit Margin
0.15%1.91%-3.17%-20.85%5.92%-19.89%
Upgrade
Free Cash Flow Margin
0.28%-1.48%6.59%-21.43%-9.98%-32.60%
Upgrade
EBITDA
4,5725,1252,299-16,3337,361-44.07
Upgrade
EBITDA Margin
4.59%5.45%2.03%-16.06%6.49%-0.05%
Upgrade
D&A For EBITDA
3,7853,8544,1073,8313,1622,972
Upgrade
EBIT
787.041,272-1,808-20,1644,199-3,016
Upgrade
EBIT Margin
0.79%1.35%-1.60%-19.83%3.70%-3.70%
Upgrade
Effective Tax Rate
----2.91%-
Upgrade
Advertising Expenses
-99.73156.14198.06120.84311.42
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.